Table 1. Patient characteristics for both groups and p-values indicating significant differences.
| Patient characteristics | 2019 | 2020 | p-value |
|---|---|---|---|
| n | 276 | 163 | |
| Age, median (IQR) | 63.0 (54–72) | 62.5 (50–74) | 0.1226 |
| Detection, n (%) Referral Screening |
155 (56.2) 121 (43.8) |
148 (90.8) 15 (9.2) |
<0.0001 |
| Node-positive on presentation, n (%) No Yes |
211 (76.4) 65 (23.6) |
104 (63.8) 59 (36.2) |
0.0063 |
| Metastatic on presentation, n (%) No Yes |
268 (97.1) 8 (2.9) |
150 (92.0) 13 (8.0) |
0.0295 |
| Median UICC stage at detection Overall Referral Screening |
1a 1b 1a |
2a 2a 2a |
<0.0001 0.0184 0.0445 |
IQR: Interquartile range; UICC: Union for International Cancer Control.